Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-24-001933
Filing Date
2024-12-23
Accepted
2024-12-23 16:02:08
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4338
  Complete submission text file 0001640334-24-001933.txt   5993
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Issuer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARTELO BIOSCIENCES, INC. 888 PROSPECT ST, SUITE 210 LA JOLLA CA 92037
Business Address
Blayney Douglas (Reporting) CIK: 0001772396 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38951 | Film No.: 241573535